Fisher Asset Management LLC maintained its position in LivaNova PLC (NASDAQ:LIVN) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 52,000 shares of the company’s stock at the end of the third quarter. Fisher Asset Management LLC’s holdings in LivaNova PLC were worth $3,126,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in LIVN. LS Investment Advisors LLC boosted its position in LivaNova PLC by 70.7% in the second quarter. LS Investment Advisors LLC now owns 2,840 shares of the company’s stock worth $143,000 after buying an additional 1,176 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in LivaNova PLC by 1.9% in the second quarter. PNC Financial Services Group Inc. now owns 2,916 shares of the company’s stock worth $147,000 after buying an additional 54 shares in the last quarter. Advisory Services Network LLC boosted its position in LivaNova PLC by 7.8% in the second quarter. Advisory Services Network LLC now owns 3,508 shares of the company’s stock worth $176,000 after buying an additional 253 shares in the last quarter. Capstone Asset Management Co. purchased a new position in LivaNova PLC during the second quarter worth approximately $204,000. Finally, Quantitative Systematic Strategies LLC purchased a new position in LivaNova PLC during the second quarter worth approximately $208,000. 63.89% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for LivaNova PLC (NASDAQ:LIVN)

Shares of LivaNova PLC (NASDAQ:LIVN) traded down 1.53% during midday trading on Wednesday, reaching $44.27. 300,369 shares of the company were exchanged. LivaNova PLC has a 52 week low of $40.83 and a 52 week high of $63.21. The firm’s market capitalization is $2.16 billion. The firm has a 50-day moving average of $50.12 and a 200 day moving average of $53.56.

LivaNova PLC (NASDAQ:LIVN) last issued its earnings results on Wednesday, November 2nd. The company reported $0.78 EPS for the quarter, beating the Zacks’ consensus estimate of $0.75 by $0.03. The business earned $295.30 million during the quarter, compared to analysts’ expectations of $299.40 million. LivaNova PLC had a negative net margin of 5.51% and a positive return on equity of 4.42%. On average, equities research analysts expect that LivaNova PLC will post $3.00 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This news story was originally published by Daily Political and is the propert of of Daily Political. If you are viewing this news story on another site, it was stolen and reposted in violation of United States and international copyright law. The correct version of this news story can be accessed at http://www.dailypolitical.com/2016/11/30/livanova-plc-livn-stake-maintained-by-fisher-asset-management-llc.html.

LIVN has been the subject of a number of recent analyst reports. Canaccord Genuity dropped their price target on shares of LivaNova PLC from $67.00 to $54.00 and set a “hold” rating for the company in a research note on Thursday, November 3rd. WBB Securities reiterated a “hold” rating and set a $60.00 price objective on shares of LivaNova PLC in a report on Wednesday, August 31st. Finally, Piper Jaffray Cos. reiterated an “overweight” rating and set a $70.00 price objective (up previously from $59.00) on shares of LivaNova PLC in a report on Friday, August 5th. Five equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. LivaNova PLC presently has a consensus rating of “Hold” and a consensus target price of $62.50.

In related news, major shareholder Two S.C.A. Equinox sold 391,379 shares of the firm’s stock in a transaction dated Wednesday, September 21st. The shares were sold at an average price of $60.69, for a total transaction of $23,752,791.51. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.70% of the company’s stock.

About LivaNova PLC

LivaNova PLC is a medical technology company. The Company operates through three segments: Cardiac Surgery, Cardiac Rhythm Management (CRM) and Neuromodulation. The Cardiac Surgery business unit is engaged in the development, production and sale of cardiovascular surgery products, including oxygenators, heart-lung machines, perfusion tubing systems and systems for autotransfusion and autologous blood washing.

5 Day Chart for NASDAQ:LIVN

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.